Wai Yuen Tong Medicine Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-16.00
-8.00
-48.00
-307.00
439.00
81.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-86.00
-35.00
-75.00
299.00
-47.00
42.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
100.00
88.00
116.00
358.00
9.00
50.00
Cash Flow from Investing Activities
-139.00
17.00
-15.00
-81.00
337.00
-208.00
Cash Flow from Financing Activities
-318.00
-67.00
-115.00
-266.00
-36.00
-84.00
Net Cash Inflow / Outflow
-366.00
27.00
17.00
44.00
303.00
-249.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-8.00
-12.00
32.00
34.00
-6.00
-6.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Wai Yuen Tong Medicine Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-16.166
578.428109089918
-594.00
-102.79%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-86.974
-823.056719234936
737.00
89.43%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
100.161
407.443349829474
-307.00
-75.42%
Cash Flow from Investing Activities
-139.019
-238.955261391302
99.00
41.82%
Cash Flow from Financing Activities
-318.996
200.341335709922
-518.00
-259.23%
Net Cash Inflow / Outflow
-366.686
385.106285414138
-751.00
-195.22%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-8.832
16.2768612660459
-24.00
-154.26%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 12.92% vs -23.66% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
100.16
88.70
12.92%






